Section one: Contracting authority
one.1) Name and addresses
NHS DORSET INTEGRATED CARE BOARD
County Hall Colliton Park
Dorchester
DT1 1XJ
dorsetprocurement@nhsdorset.nhs.uk
Telephone
+44 1305368900
Country
United Kingdom
Region code
UKK25 - Dorset
NHS Dorset United Kingdom
NHS
Internet address(es)
Main address
one.4) Type of the contracting authority
Regional or local authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Provision of a Community Weight Management Service for Dorset
two.1.2) Main CPV code
- 85323000 - Community health services
two.1.3) Type of contract
Services
two.1.4) Short description
This service will serve Service Users aged 18 and over registered with a Dorset GP practice who comply with the thresholds contained within the Evidence Based Intervention Policy for Specialist Weight Management Services.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £4,500,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKC - North East (England)
- UKD - North West (England)
- UKE - Yorkshire and the Humber
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKI - London
- UKJ - South East (England)
- UKK - South West (England)
two.2.4) Description of the procurement
This service will serve Service Users aged 18 and over registered with a Dorset GP practice who comply with the thresholds contained within the Evidence Based Intervention Policy for Specialist Weight Management Services.
Service
• All Service Users must be eligible and currently prescribed the approved treatment option (tirzepatide) in this service.
• All Service Users will have a documented individualised treatment that recognises any co-morbidities and personalisation of care.
• All Service users will be offered a range of appointments, including face-to-face, group or digital appointments.
• All service users will be offered appointments at various times, including evening and weekends.
• All service users not qualifying for ongoing weight loss medication must be signposted to alternative support in line with the weight management pathway in Appendix A and discharged from the service.
Outcome Measures
• 75% of service users will report an improvement in physical and mental well-being, as measured by a standardised quality of life scores within 12 weeks of joining the programme.
• 75% of service users will report adoption of sustainable healthy eating habits, regular physical activity, and positive behavioural changes within 12 weeks of joining the programme.
First 72 weeks
• All service users must have a quarterly review after reaching maximum tolerated dose of medication.
• All service users must engage with local or nationally commissioned wraparound services that support psychological, calorie restriction and exercise as specified while being prescribed the weight-loss medication otherwise it should be withdrawn.
• 95% of service users should continue to attend follow-up appointments and maintain a body weight reduction of 15% at 72 weeks dependent on the dose of medicine prescribed .
• 90% reduction in the risk of progression to type 2 diabetes for all service users.
Maintenance after 72 weeks
• 95% of all service users must continue to lose or maintain minimum 15% from baseline weight loss over a period of three years.
• Diversion of medicines will result in service users being declined further pharmacological therapy.
• Where weight loss targets are maintained and engagement with follow-up and wraparound services completed, service users may be prescribed therapy for the 3-year initial treatment on advice from their healthcare professional prior to evaluation of the service by NHS England or replacement body.
two.2.5) Award criteria
Cost criterion - Name: Technical & Quality / Weighting: 70%
Cost criterion - Name: Social Value / Weighting: 10%
Cost criterion - Name: Price / Weighting: 20%
two.2.11) Information about options
Options: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2025/S 000-041262
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
10 October 2025
five.2.2) Information about tenders
Number of tenders received: 12
The contract has been awarded to a group of economic operators: Yes
five.2.3) Name and address of the contractor
Modality LLP
Wolverhampton
Country
United Kingdom
NUTS code
- UKG3 - West Midlands
Companies House
OC422179
The contractor is an SME
Yes
five.2.3) Name and address of the contractor
Modality LLP
Wolverhampton
Country
United Kingdom
NUTS code
- UKG - West Midlands (England)
Companies House
OC422179
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £4,500,000
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
10 October 2025
five.2.2) Information about tenders
Number of tenders received: 12
The contract has been awarded to a group of economic operators: Yes
five.2.3) Name and address of the contractor
MID DORSET PRIMARY HEALTHCARE LIMITED
Dorchester
Country
United Kingdom
NUTS code
- UKK - South West (England)
Companies House
09752937
The contractor is an SME
Yes
five.2.3) Name and address of the contractor
MID DORSET PRIMARY HEALTHCARE LIMITED
Dorchester
Country
United Kingdom
NUTS code
- UKK - South West (England)
Companies House
09752937
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £4,500,000
Total value of the contract/lot: £4,500,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
NHS England
London
Country
United Kingdom